000303966 001__ 303966
000303966 005__ 20250823114644.0
000303966 0247_ $$2doi$$a10.1038/s41416-025-03038-w
000303966 0247_ $$2pmid$$apmid:40835748
000303966 0247_ $$2ISSN$$a0007-0920
000303966 0247_ $$2ISSN$$a1532-1827
000303966 037__ $$aDKFZ-2025-01735
000303966 041__ $$aEnglish
000303966 082__ $$a610
000303966 1001_ $$00000-0001-8994-9332$$aStøer, Nathalie C$$b0
000303966 245__ $$aCorrection: Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.
000303966 260__ $$aEdinburgh$$bNature Publ. Group$$c2025
000303966 3367_ $$2DRIVER$$aarticle
000303966 3367_ $$2DataCite$$aOutput Types/Journal article
000303966 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1755860803_12319$$xErratum/Correction
000303966 3367_ $$2BibTeX$$aARTICLE
000303966 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303966 3367_ $$00$$2EndNote$$aJournal Article
000303966 500__ $$aDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. / epub
000303966 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000303966 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303966 7001_ $$00000-0003-4681-4774$$aVangen, Siri$$b1
000303966 7001_ $$aSingh, Deependra$$b2
000303966 7001_ $$0P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2$$aTurzanski-Fortner, Renée$$b3$$udkfz
000303966 7001_ $$00000-0003-0178-8939$$aHofvind, Solveig$$b4
000303966 7001_ $$aUrsin, Giske$$b5
000303966 7001_ $$aBotteri, Edoardo$$b6
000303966 773__ $$0PERI:(DE-600)2002452-6$$a10.1038/s41416-025-03038-w$$pnn$$tBritish journal of cancer$$vnn$$x0007-0920$$y2025
000303966 909CO $$ooai:inrepo02.dkfz.de:303966$$pVDB
000303966 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000303966 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000303966 9141_ $$y2025
000303966 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-19$$wger
000303966 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBRIT J CANCER : 2022$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-19
000303966 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bBRIT J CANCER : 2022$$d2024-12-19
000303966 9201_ $$0I:(DE-He78)C180-20160331$$kC180$$lKrebsepidemiologie$$x0
000303966 980__ $$ajournal
000303966 980__ $$aVDB
000303966 980__ $$aI:(DE-He78)C180-20160331
000303966 980__ $$aUNRESTRICTED